Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

836
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
836
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

4.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Few-mode fiber based Raman distributed temperature sensing.

Optics express·2017
Same author

Tripodal S-Ligand Complexes of Copper(I) as Catalysts for Alkene Aziridination, Sulfide Sulfimidation, and C-H Amination.

Inorganic chemistry·2017
Same author

5-aminolevulinic acid-mediated photodynamic therapy and its strain-dependent combined effect with antibiotics on Staphylococcus aureus biofilm.

PloS one·2017
Same author

Optimized Multiresidue Analysis of Organic Contaminants of Priority Concern in a Daily Consumed Fish (Grass Carp).

Journal of analytical methods in chemistry·2017
Same author

Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.

International journal of oncology·2017
Same author

Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2017

Related Experiment Video

Updated: Dec 23, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.9K

Bacterial outer membrane vesicles as a platform for biomedical applications: An update.

Min Li1, Han Zhou2, Chen Yang2

  • 1College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, Guangdong 518060, China; Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|April 26, 2020
PubMed
Summary

Outer membrane vesicles (OMVs) are nano-sized bacterial components with biomedical potential. This review explores OMV structure, isolation methods, and applications in vaccines, immunotherapy, and drug delivery.

Keywords:
AdjuvantsAnti-bacteria adhesion agentsBacterial vaccinesCancer immunotherapy agentsDrug delivery vehiclesOuter membrane vesicles

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 23, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.4K
Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria
09:56

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Published on: October 13, 2021

4.5K

Area of Science:

  • Microbiology
  • Biotechnology
  • Nanomedicine

Background:

  • Gram-negative bacteria produce outer membrane vesicles (OMVs), which are nano-sized lipid bilayer structures containing bacterial components.
  • OMVs possess bacterial antigens, pathogen-associated molecular patterns (PAMPs), adhesins, and proteins, making them valuable for biomedical uses.

Purpose of the Study:

  • To analyze the structure-composition-application relationship of OMVs.
  • To summarize OMV isolation and characterization techniques.
  • To highlight recent advancements and future directions for OMVs in biomedicine.

Main Methods:

  • Literature review of studies on OMV structure, composition, isolation, characterization, and applications.
  • Analysis of how OMV properties influence their use in various biomedical fields.

Main Results:

  • OMVs serve as versatile platforms for bacterial vaccines, adjuvants, cancer immunotherapy, drug delivery, and anti-adhesion agents.
  • The structural and compositional characteristics of OMVs are crucial for their efficacy in these applications.

Conclusions:

  • OMVs offer significant potential in diverse biomedical applications due to their inherent properties.
  • Further research into OMV isolation, characterization, and application development is warranted.